CDC Just Posted a $1.26 Billion Cancer NOFO With 196 Awards. The Award Count Is Almost Exactly the Number of Programs It Already Funds.

On September 3, 2026, CDC's National Center for Chronic Disease Prevention and Health Promotion posted CDC-RFA-DP-27-0023, "Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations." Estimated total program funding: $1,260,000,000. Estimated number of awards: 196. Applications close February 5, 2027, and the opportunity archives March 7, 2027.

That is, by a wide margin, the largest single notice of funding opportunity posted to Grants.gov during the first week of September. It is also one of the least understood, because the headline number describes something that is not a program. It is three programs, wearing one NOFO number, with three different statutes governing who may apply to each.

Before you calculate an average award size and get excited, do the other arithmetic.

The award count is the story

CDC's Division of Cancer Prevention and Control already funds these three programs, and the size of each recipient pool is public.

The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) funds all 50 states, the District of Columbia, Puerto Rico, five U.S.-Affiliated Pacific Islands, and 13 tribes or tribal organizations. Under the predecessor NOFO, DP22-2202, that came to 71 award recipients.

The National Comprehensive Cancer Control Program (NCCCP) supports all 50 states, the District of Columbia, eight U.S. territories and freely associated states, and seven tribes or tribal organizations — 66 recipients.

The National Program of Cancer Registries (NPCR) funds 50 central cancer registries: 46 states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, and the Pacific Island Jurisdictions. Together those registries cover roughly 97 percent of the U.S. population, and combined with NIH's SEER program the coverage is complete.

71 plus 66 plus 50 is 187. The NOFO estimates 196 awards.

That is not a competition designed to bring in a wave of new organizations. It is a recompete of the existing footprint, with roughly nine slots of headroom — enough for a handful of additional tribal or territorial recipients, or for optional components that split into separate award actions, and not much more.

If you are an incumbent, this is a defend-your-seat competition. If you are not, the honest read is that your realistic path runs through partnership with a jurisdiction that holds one of the 187, not around it.

Three statutes, three eligibility pools

The eligibility language in the posting is unusually blunt about this, and it is the single most important paragraph in the announcement.

The applicant-type list you see on the Grants.gov summary — state governments, county governments, city or township governments, public and private institutions of higher education, nonprofits with and without 501(c)(3) status, federally recognized tribal governments, other tribal organizations — applies only to Program 2, the NCCCP. That is the open one.

Program 1, NBCCEDP, is limited by statute. Funds go to state health departments and the District of Columbia; U.S. territories and freely associated states; federally recognized American Indian tribes, tribal organizations, Alaska Native organizations, and Urban Indian organizations; or their bona fide agents. The authority is the Breast and Cervical Cancer Mortality Prevention Act of 1990.

Program 3, NPCR, is limited by statute to state governments including the District of Columbia, U.S. territories and freely associated states, tribal governments (federally recognized or state-recognized) and tribal designated organizations, and bona fide agents applying on behalf of those entities. The authority is the Cancer Registries Amendment Act. Bona fide agents must submit documentation demonstrating their arrangement with the eligible applicant.

That last requirement is where universities and nonprofit cancer organizations actually enter this NOFO. A university-based registry operating a state central cancer registry under contract is not eligible in its own right — it is eligible as the state's bona fide agent, and the documentation of that arrangement is a submission requirement, not a courtesy attachment. If your institution runs a state registry and you have not confirmed in writing who is submitting and under what designation, that is the first call to make, and February is not as far away as it sounds when a state health department has to authorize a designation.

What each program actually buys

NBCCEDP has two components. Component A supports breast and cervical cancer screening and diagnostic follow-up for women with low incomes who do not have adequate insurance. Component B is optional and supports implementation of evidence-based interventions shown to increase screening rates.

The program's history explains the split. Congress passed the Breast and Cervical Cancer Mortality Prevention Act in 1990 and appropriated $30 million for the first year; CDC funded the first eight states in the summer of 1991. The Preventive Health Amendments of 1993 authorized funding for tribes and tribal organizations. The Breast and Cervical Cancer Prevention and Treatment Act of 2000 created the Medicaid pathway that lets states offer treatment to women diagnosed through the program. Since 1991, NBCCEDP programs have delivered more than 16 million breast and cervical cancer screening tests and found more than 80,000 breast cancers and more than 5,000 cervical cancers.

The tension inside that record is the reason Component B exists. Peer-reviewed analysis of 2018–2021 data found the program served roughly 13.5 percent of women eligible for its breast cancer screening services. Direct-service dollars alone were never going to close a gap that large, which is why CDC pushed recipients toward population-level evidence-based interventions — client reminders, provider assessment and feedback, reducing structural barriers — that move screening rates for people the clinical program will never personally serve. Expect Component B narratives to be scored on whether you can distinguish those two theories of change rather than blur them.

NCCCP funds cancer coalitions to plan and implement evidence-based strategies described in jurisdiction-wide cancer plans. It is the program with the broadest eligibility and the least direct service. Its currency is the cancer plan itself and the coalition's demonstrated ability to move partners it does not control.

NPCR funds population-based central cancer registries. This is infrastructure: case ascertainment, data quality, timeliness, and the reporting that makes United States Cancer Statistics possible.

The NOFO's stated theory is that these three "working together through partnerships, coordination of resources and efforts, consistent communication, and community involvement" get closer to the division's mission than any one of them alone. That is not decoration. In a NOFO that deliberately binds three programs to one deadline, cross-program integration is the thing the reviewers are being asked to reward, and it is the easiest thing to fake and the easiest to catch. A registry application that describes how its data feeds the coalition's plan, and a coalition application that names the registry indicators it will move, are worth more together than either is alone — and jurisdictions that submit to two or three programs should be reading each other's drafts.

The dollars, read carefully

$1.26 billion across 196 awards is about $6.4 million per award — but that is the total across the full period of performance, not an annual figure. The predecessor, DP22-2202, was a five-year NOFO. If DP-27-0023 holds the same structure, the annual run rate is roughly $252 million, and the average annual award is closer to $1.3 million. NBCCEDP alone has historically operated on roughly a $100 million annual budget, which anchors the scale.

The posting lists an award ceiling of $0, which in Grants.gov practice means "not specified in the summary" rather than "no money." The per-award caps live in the full NOFO document, and they will differ sharply by program and by component — a Pacific Island jurisdiction's registry award and a large state's NBCCEDP Component A award are not the same order of magnitude.

One field deserves independent verification: the summary flags cost sharing as required. That is unusual for this family of CDC cooperative agreements, and NBCCEDP's statutory structure has its own matching history. Do not budget a match — or assume its absence — off the Grants.gov summary field. Read the section in the NOFO document and, if it is ambiguous, write to DP270023@cdc.gov early. Match questions asked in January get answered after your budget is locked.

The five-month runway is not five months

Applications close February 5, 2027. For a state health department that intends to submit to two or three programs, the real calendar is shorter than that, in three specific ways.

Bona fide agent designations take weeks. If a university, a hospital system, or a nonprofit is submitting on a state's behalf for NPCR or NBCCEDP, the documentation of that arrangement has to be executed and attached. That is a legal signature, not a form field.

Coalition letters are a scheduling problem, not a writing problem. NCCCP applications live or die on evidence that partners will actually do the work. Coalitions meet quarterly. Count how many meetings fall before February 5 and work backward from the last one at which you could realistically get commitments ratified.

Three applications from one jurisdiction need one editor. The integration story is the differentiator, and integration written by three separate teams reads like three separate applications with a shared paragraph. Name the person who owns coherence across all three before anyone starts drafting.

What to do this month

If you hold a DP22-2202 award, pull your current work plan and your most recent progress report now, while the NOFO is fresh, and mark every objective you did not hit. Recompetes are won on candor about what did not work plus a credible account of why the next five years differ — not on a restatement of the last application.

If you are eligible only for Program 2, decide early whether you are the applicant or the partner. A coalition that is genuinely stronger as a subrecipient to the health department should say so and negotiate scope, rather than mount a competing application against an incumbent with 187 peers.

If you are not eligible for anything here, the productive move is to identify which of the 187 incumbents in your state is closest to your mission and ask what their February submission needs. Evidence-based intervention implementation under NBCCEDP Component B and coalition-implemented strategies under NCCCP are both delivered largely through subawards. That is a real door, and it opens in the fall, not in February.

For broader context on how federal health funding is being restructured this year, see our analysis of the OMB Uniform Guidance rewrite and its October 1 effective date — a five-year cooperative agreement signed in 2027 will be governed by whatever emerges from that rulemaking, not by the rules in force when you write.

Verify all figures, eligibility, and deadlines against the official NOFO document on Grants.gov before applying. Program contact: DP270023@cdc.gov.